For those trying to eat a healthy diet, whole-fat dairy and trans fats are usually not on the menu - at least, not yet. Scientists have narrowed in on a trans fat component found mainly in dairy fat that may ward off type 2 diabetes and protect cardiovascular health. While the research is far from conclusive and requires much further study, it suggests fats may play a more complex role in human health than previously thought.
With nearly 16 million Americans living today with pre-diabetes, a condition that is the precursor to type 2 diabetes, and half of all Americans expected to have some form of diabetes by the year 2020, healthy eating is more important than ever (1,2). But here is some good news: a recent scientific study shows that incorporating almonds into your diet can help treat and possibly prevent type 2 diabetes, as well as cardiovascular disease.
An intensive lifestyle intervention program designed with weight loss in mind improves diabetes control and cardiovascular disease risk factors in overweight and obese individuals with type 2 diabetes. These are the findings of the four-year Look AHEAD study, funded by the National Institutes of Health and the Centers for Disease Control and Prevention. Look AHEAD (Action for Health in Diabetes) is a multi-center, randomized clinical trial evaluating the effect of reduced caloric intake and increased physical activity on the incidence of major cardiovascular events such as heart attack, stroke, and cardiovascular-related death.
A meta-analysis* of 87 studies involving 951,083 patients, performed by a Canadian research team, shows that the pre-diabetic condition known as metabolic syndrome increases the risk of heart disease or stroke in patients by a factor of more than two.
The U.S. Food and Drug Administration's (FDA) Joint Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee has completed their evaluation of the scientific research available on the safety of rosiglitazone. The deliberations of the panel reflected the complexity of the issues, with several members voting to add additional warnings or to withdraw the drug from the U.S. market. Ultimately, the final recommendation was to allow Avandia to remain on the market. Now that the expert panel has concluded its meeting, the FDA will review their recommendations and make the final decision on whether the drug remains available to patients.
Data from the massive ACCORD study on intensive blood sugar control shows that lowering blood sugar levels in people with longstanding type 2 diabetes to near-normal may delay the appearance of signs that point to damage to nerves, eyes, and kidneys, but does not stop their progression toward it.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.